Compare 10X Genomics Inc (TXG) vs ProShares UltraPro S&P500 (UPRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs ProShares UltraPro S&P500 — how do they compare? 10X Genomics Inc trades at $47.2 (market cap $5.48B), while ProShares UltraPro S&P500 trades at $141.7. The key difference: 10X Genomics Inc is trading nearer its 52-week high, ProShares UltraPro S&P500 nearer its low. Which is the better fit depends on your goals.
| TXG | UPRO | |
|---|---|---|
Market Cap | $5.48B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $45.80 | $150.93 |
52-Week Low | $11.34 | $89.29 |
Enterprise Value | $5.02B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About ProShares UltraPro S&P500
UPRO is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the S&P 500 Index. It is a tactical, high-conviction instrument designed for short-term traders to amplify bullish market moves, utilizing a daily reset mechanism that creates significant compounding effects and volatility risks over time.
Read more on UPRO →
